Endothelium dysfunction in LDL receptor knockout mice: a role for H2O2

Br J Pharmacol. 2003 Apr;138(7):1215-20. doi: 10.1038/sj.bjp.0705164.

Abstract

1. In this study, the role of endogenous H(2)O(2) as an endothelium-dependent relaxant factor was characterised in aortas from C57BL/6J and LDL receptor-deficient mice (LDLR(-/-)). 2. Aortic rings from LDLR(-/-) mice showed impaired endothelium-dependent relaxation to acetylcholine (ACh; 0.001-100 micro M) and to the Ca(2+) ionophore A23187 (0.001-3 micro M) compared with aortic rings from control mice. Endothelium-independent relaxation produced by the NO donor, 3-morpholino-sydnonimine (SIN-1) was not different between strains. 3. Pretreatment of vessels with L-NNA (100 micro M) or L-NNA (100 micro M) plus L-NAME (300 micro M) plus haemoglobin (10 micro M) markedly decreased, but did not abolish the relaxation to ACh in control mice. In the aortas from LDLR(-/-) mice treated with L-NNA (100 micro M), ACh induced a contractile effect. Catalase (800 and 2400 U ml(-1)) shifted to the right the endothelium-dependent relaxation to ACh in aortas from control but not from LDLR(-/-) mice. Aminotriazole (50 mM), which inhibits catalase, abolished its effect on control mice. Treatment of vessels with L-NNA and catalase abolished vasorelaxation induced by ACh. Indomethacin (10 micro M) did not modify the concentration-response curve to ACh. Superoxide dismutase (300 U ml(-1)) did not change ACh-induced relaxation in both strains. 4. Exogenous H(2)O(2) produced a concentration-dependent relaxation in endothelium-denuded aortic rings, which was not different between strains. 5. It is concluded that H(2)O(2) greatly contributes to relaxation to ACh in aorta from control mice. Endothelial-dependent relaxation to ACh is impaired in LDLR(-/-) mice. Reduced biosynthesis or increased inactivation of H(2)O(2) is the possible mechanism responsible for endothelial dysfunction in aortas of atherosclerosis-susceptible LDLR(-/-) mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism
  • Acetylcholine / pharmacology
  • Amitrole / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / metabolism
  • Arteriosclerosis*
  • Catalase / pharmacology
  • Endothelium / abnormalities*
  • Endothelium / metabolism*
  • Endothelium-Dependent Relaxing Factors / metabolism*
  • Endothelium-Dependent Relaxing Factors / pharmacology
  • Hydrogen Peroxide / metabolism*
  • Hydrogen Peroxide / pharmacology
  • Indomethacin / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout / genetics*
  • Mice, Knockout / metabolism*
  • Molsidomine / analogs & derivatives*
  • Molsidomine / pharmacology
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitroarginine / pharmacology
  • Phenylephrine
  • Receptors, LDL / deficiency*
  • Receptors, LDL / genetics*
  • Superoxide Dismutase / pharmacology

Substances

  • Endothelium-Dependent Relaxing Factors
  • Receptors, LDL
  • Phenylephrine
  • Nitroarginine
  • linsidomine
  • Hydrogen Peroxide
  • Molsidomine
  • Catalase
  • Superoxide Dismutase
  • Acetylcholine
  • NG-Nitroarginine Methyl Ester
  • Indomethacin
  • Amitrole